Delivery Order SPE2DB20D2104-SPE2DB23FR40X
- Not listed
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $5,922.14 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of VASCEPA 1 GM CAPSULE 120S. The contract has an ultimate completion date of February 9, 2024 and was awarded on February 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,201.32 and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This is a firm fixed price delivery order (SPE2DX24F0HD5) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, the prime contractor, for the pharmaceutical product VASCEPA 1 GM CAPSULE 120S. The order has a ceiling value of $2,639.65 and a performance period through April 9, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). This award is part of a larger DLA indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,282.17 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract has a completion date of February 16, 2024 and was awarded on February 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,099.20 firm fixed-price delivery order is for the provision of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product, with a completion date of May 19, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,699.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order that provides various pharmaceutical products, including capsules, to support military healthcare programs. The award has an ultimate completion date of November 7, 2023 and is a firm fixed price contract. This appears to be part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,785.25 for pharmaceutical and medical supply products. The award was made by the Defense Logistics Agency (DLA) and is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the...
- This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $1,323.73 and a completion date of December 11, 2023. It is a firm-fixed-price delivery order contract, awarded on December 8, 2022. The contract is not...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,151.12 awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,487.26 for pharmaceutical and medical supply products. The contract was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating full and open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR40XDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $2,664.96 for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. In addition to the DLA contract, Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/12/22 |